Difficulty: Medium
Average Score: 92%
Practice
Which information about prevention of lung disease should the nurse include for a patient with a 42 pack-year history of cigarette smoking?
Correct answer
A
Rationale
The correct answer to the question is option A) Resources for support in smoking cessation. This is the most appropriate information to include for a patient with a 42 pack-year history of cigarette smoking because smoking cessation is the single most effective way to prevent further lung damage and reduce the risk of developing lung diseases such as chronic obstructive pulmonary disease (COPD) and lung cancer.
Option B) Reasons for annual sputum cytology testing is incorrect because while sputum cytology testing may be part of lung cancer screening protocols for high-risk individuals, it is not the most crucial information to provide to a patient with a significant smoking history.
Option C) Erlotinib (Tarceva) therapy to prevent tumor risk is also incorrect as this medication is typically used in the treatment of non-small cell lung cancer and is not indicated for primary prevention in a patient with a smoking history.
Option D) Computed tomography (CT) screening for cancer is not the most appropriate information to provide as the initial focus should be on smoking cessation rather than solely on cancer screening.
In an educational context, it is important for nurses to understand the critical role of smoking cessation in preventing lung disease and to prioritize providing support and resources to patients with a history of smoking. By emphasizing the benefits of quitting smoking and connecting patients with appropriate cessation programs, nurses can significantly impact the health outcomes of individuals at risk for lung diseases related to smoking.
Option B) Reasons for annual sputum cytology testing is incorrect because while sputum cytology testing may be part of lung cancer screening protocols for high-risk individuals, it is not the most crucial information to provide to a patient with a significant smoking history.
Option C) Erlotinib (Tarceva) therapy to prevent tumor risk is also incorrect as this medication is typically used in the treatment of non-small cell lung cancer and is not indicated for primary prevention in a patient with a smoking history.
Option D) Computed tomography (CT) screening for cancer is not the most appropriate information to provide as the initial focus should be on smoking cessation rather than solely on cancer screening.
In an educational context, it is important for nurses to understand the critical role of smoking cessation in preventing lung disease and to prioritize providing support and resources to patients with a history of smoking. By emphasizing the benefits of quitting smoking and connecting patients with appropriate cessation programs, nurses can significantly impact the health outcomes of individuals at risk for lung diseases related to smoking.